{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T21:17:22Z","timestamp":1793222242893,"version":"4.5.0"},"reference-count":79,"publisher":"Bioscientifica","issue":"2","content-domain":{"domain":["joe.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,3,7]]},"abstract":"<jats:p>Glucocorticoids are steroid hormones, secreted by the adrenals to regulate a range of metabolic, immunologic, and homeostatic functions. Due to their potent anti-inflammatory effects, synthetic glucocorticoids are widely used to treat inflammatory disorders. However, their use especially at high doses and over the long-term is associated with several unwanted side effects that compromises their intended use (e.g. glucocorticoid-induced osteoporosis and\/or diabetes, myopathy, and skin atrophy). Both endogenous and synthetic glucocorticoids exert their effects through the glucocorticoid receptor, a transcription factor present in nearly all nucleated cells. Glucocorticoid receptor knockout mouse models have proved to be valuable tools in understanding how glucocorticoids contribute to skeletal health and disease. These models, described in this review, have helped to establish that the effects of glucocorticoids on the skeleton are multifaceted, cell specific and concentration dependent. Intriguingly, while endogenous glucocorticoids are essential for bone formation, high-dose exogenous glucocorticoids may induce bone loss. Additionally, the actions of endogenous glucocorticoids vary greatly depending on the disease microenvironment. For example, endogenous glucocorticoids have predominately beneficial anti-inflammatory effects in rheumatoid arthritis, but detrimental actions in osteoarthritis by driving cartilage loss and abnormal bone formation. Studies in tissue-specific knockout models provide important insights that will aid the development of new glucocorticoid therapeutics that can specifically target certain cell types to minimise unwanted effects from current glucocorticoid therapy.<\/jats:p>","DOI":"10.1530\/joe-23-0399","type":"journal-article","created":{"date-parts":[[2024,3,7]],"date-time":"2024-03-07T12:59:50Z","timestamp":1709816390000},"update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-5","source":"Crossref","is-referenced-by-count":7,"title":["The glucocorticoid receptor in skeletal health and disease: insights from targeted knockout mice"],"prefix":"10.1530","volume":"261","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3608-3285","authenticated-orcid":true,"given":"Eugenie","family":"Macfarlane","sequence":"first","affiliation":[{"name":"Bone Research Program, ANZAC Research Institute, The University of Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5899-9660","authenticated-orcid":true,"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[{"name":"Bone Research Program, ANZAC Research Institute, The University of Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2701-378X","authenticated-orcid":true,"given":"Markus J","family":"Seibel","sequence":"additional","affiliation":[{"name":"Bone Research Program, ANZAC Research Institute, The University of Sydney, Australia"},{"name":"Department of Endocrinology and Metabolism, Concord Repatriation General Hospital, Sydney, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"416","reference":[{"key":"bib1","series-title":"Bone Research","first-page":"19","article-title":"The art of building bone: emerging role of chondrocyte-to-osteoblast transdifferentiation in endochondral ossification","volume":"6","author":"Aghajanian","year":"2018","unstructured":"Aghajanian P & Mohan S2018The art of building bone: emerging role of chondrocyte-to-osteoblast transdifferentiation in endochondral ossification. Bone Research619. (https:\/\/doi.org\/10.1038\/s41413-018-0021-z)"},{"key":"bib2","series-title":"Bone","first-page":"253","article-title":"High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study","volume":"39","author":"Angeli","year":"2006","unstructured":"Angeli AGuglielmi GDovio ACapelli GDe Feo DGiannini SGiorgino RMoro L & Giustina A2006High prevalence of asymptomatic vertebral fractures in post-menopausal women receiving chronic glucocorticoid therapy: a cross-sectional outpatient study. Bone39253\u2013259. (https:\/\/doi.org\/10.1016\/j.bone.2006.02.005)"},{"key":"bib3","series-title":"Endocrine Reviews","first-page":"351","article-title":"Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor","volume":"7","author":"Antoni","year":"1986","unstructured":"Antoni FA1986Hypothalamic control of adrenocorticotropin secretion: advances since the discovery of 41-residue corticotropin-releasing factor. Endocrine Reviews7351\u2013378. (https:\/\/doi.org\/10.1210\/edrv-7-4-351)"},{"key":"bib4","series-title":"PNAS","first-page":"19317","article-title":"Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells","volume":"108","author":"Baschant","year":"2011","unstructured":"Baschant UFrappart LRauchhaus UBruns LReichardt HMKamradt TBrauer R & Tuckermann JP2011Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells. PNAS10819317\u201319322. (https:\/\/doi.org\/10.1073\/pnas.1105857108)"},{"key":"bib5","series-title":"Cell","first-page":"93","article-title":"Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition","volume":"110","author":"Bledsoe","year":"2002","unstructured":"Bledsoe RKMontana VGStanley TBDelves CJApolito CJMcKee DDConsler TGParks DJStewart ELWillson TM, et al.2002Crystal structure of the glucocorticoid receptor ligand binding domain reveals a novel mode of receptor dimerization and coactivator recognition. Cell11093\u2013105. (https:\/\/doi.org\/10.1016\/s0092-8674(0200817-6)"},{"key":"bib6","series-title":"Vitamins and Hormones","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0083-6729(04)68002-2","article-title":"Structure and function of the glucocorticoid receptor ligand binding domain","volume":"68","author":"Bledsoe","year":"2004","unstructured":"Bledsoe RKStewart EL & Pearce KH2004Structure and function of the glucocorticoid receptor ligand binding domain. Vitamins and Hormones6849\u201391. (https:\/\/doi.org\/10.1016\/S0083-6729(0468002-2)"},{"key":"bib7","series-title":"Proceedings of the Society for Experimental Biology and Medicine","first-page":"678","article-title":"Effect of cortisone on experimental fractures in the rabbit","volume":"73","author":"Blunt","year":"1950","unstructured":"Blunt JWJrPlotz CMLattes RHowes ELMeyer K & Ragan C1950Effect of cortisone on experimental fractures in the rabbit. Proceedings of the Society for Experimental Biology and Medicine73678\u2013681. (https:\/\/doi.org\/10.3181\/00379727-73-17785)"},{"key":"bib8","series-title":"Lancet","first-page":"801","article-title":"Optimised glucocorticoid therapy: the sharpening of an old spear","volume":"365","author":"Buttgereit","year":"2005","unstructured":"Buttgereit FBurmester GR & Lipworth BJ2005Optimised glucocorticoid therapy: the sharpening of an old spear. Lancet365801\u2013803. (https:\/\/doi.org\/10.1016\/S0140-6736(0517989-6)"},{"key":"bib9","series-title":"Arthritis and Rheumatism","first-page":"1998","article-title":"Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K\/BxN mouse serum-induced arthritis in vivo","volume":"60","author":"Buttgereit","year":"2009","unstructured":"Buttgereit FZhou HKalak RGaber TSpies CMHuscher DStraub RHModzelewski JDunstan CR & Seibel MJ2009Transgenic disruption of glucocorticoid signaling in mature osteoblasts and osteocytes attenuates K\/BxN mouse serum-induced arthritis in vivo. Arthritis and Rheumatism601998\u20132007. (https:\/\/doi.org\/10.1002\/art.24619)"},{"key":"bib10","series-title":"Molecular Endocrinology","first-page":"52","article-title":"The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes","volume":"19","author":"Charmandari","year":"2005","unstructured":"Charmandari EChrousos GPIchijo TBhattacharyya NVottero ASouvatzoglou E & Kino T2005The human glucocorticoid receptor (hGR) beta isoform suppresses the transcriptional activity of hGRalpha by interfering with formation of active coactivator complexes. Molecular Endocrinology1952\u201364. (https:\/\/doi.org\/10.1210\/me.2004-0112)"},{"key":"bib11","series-title":"Cytokine and Growth Factor Reviews","first-page":"54","article-title":"Pathogenic mechanisms of glucocorticoid-induced osteoporosis","volume":"70","author":"Chen","year":"2023","unstructured":"Chen MFu WXu H & Liu CJ2023Pathogenic mechanisms of glucocorticoid-induced osteoporosis. Cytokine and Growth Factor Reviews7054\u201366. (https:\/\/doi.org\/10.1016\/j.cytogfr.2023.03.002)"},{"key":"bib12","series-title":"Genes and Development","first-page":"1608","article-title":"Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation","volume":"9","author":"Cole","year":"1995","unstructured":"Cole TJBlendy JAMonaghan APKrieglstein KSchmid WAguzzi AFantuzzi GHummler EUnsicker K & Sch\u00fctz G1995Targeted disruption of the glucocorticoid receptor gene blocks adrenergic chromaffin cell development and severely retards lung maturation. Genes and Development91608\u20131621. (https:\/\/doi.org\/10.1101\/gad.9.13.1608)"},{"key":"bib13","series-title":"Bone","first-page":"43","article-title":"Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity","volume":"93","author":"Conaway","year":"2016","unstructured":"Conaway HHHenning PLie ATuckermann J & Lerner UH2016Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity. Bone9343\u201354. (https:\/\/doi.org\/10.1016\/j.bone.2016.08.024)"},{"key":"bib14","series-title":"Endocrinology","first-page":"234","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice","volume":"153","author":"Coutinho","year":"2012","unstructured":"Coutinho AEGray MBrownstein DGSalter DMSawatzky DAClay SGilmour JSSeckl JRSavill JS & Chapman KE201211\u03b2-hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice. Endocrinology153234\u2013240. (https:\/\/doi.org\/10.1210\/en.2011-1398)"},{"key":"bib15","series-title":"Seminars in Arthritis and Rheumatism","first-page":"152219","article-title":"Time trends in glucocorticoid use in rheumatoid arthritis during the biologics era: 1999\u20132018","volume":"61","author":"Crowson","year":"2023","unstructured":"Crowson LPDavis JMHanson ACMyasoedova EKronzer VLMakol APeterson LSBekele DI & Crowson CS2023Time trends in glucocorticoid use in rheumatoid arthritis during the biologics era: 1999\u20132018. Seminars in Arthritis and Rheumatism61152219. (https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152219)"},{"key":"bib16","series-title":"Journal of Biological Chemistry","first-page":"4597","article-title":"A new first step in activation of steroid receptors: hormone-induced switching of fkbp51 and fkbp52 immunophilins","volume":"277","author":"Davies","year":"2002","unstructured":"Davies THNing YM & S\u00e1nchez ER2002A new first step in activation of steroid receptors: hormone-induced switching of fkbp51 and fkbp52 immunophilins. Journal of Biological Chemistry2774597\u20134600. (https:\/\/doi.org\/10.1074\/jbc.C100531200)"},{"key":"bib17","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"5695","article-title":"11beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids","volume":"87","author":"Diederich","year":"2002","unstructured":"Diederich SEigendorff EBurkhardt PQuinkler MBumke-Vogt CRochel MSeidelmann DEsperling POelkers W & B\u00e4hr V200211beta-hydroxysteroid dehydrogenase types 1 and 2: an important pharmacokinetic determinant for the activity of synthetic mineralo- and glucocorticoids. Journal of Clinical Endocrinology and Metabolism875695\u20135701. (https:\/\/doi.org\/10.1210\/jc.2002-020970)"},{"key":"bib18","series-title":"Journal of Clinical Endocrinology and Metabolism","first-page":"2072","article-title":"Mannheim classification of nongenomically initiated (rapid) steroid action(s)","volume":"85","author":"Falkenstein","year":"2000","unstructured":"Falkenstein ENorman AW & Wehling M2000Mannheim classification of nongenomically initiated (rapid) steroid action(s). Journal of Clinical Endocrinology and Metabolism852072\u20132075. (https:\/\/doi.org\/10.1210\/jcem.85.5.6516)"},{"key":"bib19","series-title":"Drugs","first-page":"1731","article-title":"Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events","volume":"74","author":"Fardet","year":"2014","unstructured":"Fardet L & F\u00e8ve B2014Systemic glucocorticoid therapy: a review of its metabolic and cardiovascular adverse events. Drugs741731\u20131745. (https:\/\/doi.org\/10.1007\/s40265-014-0282-9)"},{"key":"bib20","series-title":"Arthritis Research and Therapy","first-page":"188","article-title":"11\u03b2-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy","volume":"21","author":"Fenton","year":"2019","unstructured":"Fenton CGDoig CLFareed SNaylor AMorrell APAddison OWehmeyer CBuckley CDCooper MSLavery GG, et al.201911\u03b2-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy. Arthritis Research and Therapy21188. (https:\/\/doi.org\/10.1186\/s13075-019-1972-1)"},{"key":"bib21","series-title":"Arthritis Care and Research","first-page":"924","article-title":"American College of Rheumatology Guideline for the treatment of rheumatoid arthritis","volume":"73","author":"Fraenkel","year":"2021","unstructured":"Fraenkel LBathon JMEngland BRSt Clair EWArayssi TCarandang KDeane KDGenovese MHuston KKKerr G, et al.2021American College of Rheumatology Guideline for the treatment of rheumatoid arthritis. Arthritis Care and Research73924\u2013939. (https:\/\/doi.org\/10.1002\/acr.24596)"},{"key":"bib22","series-title":"Frontiers in Endocrinology","first-page":"835720","article-title":"Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes","volume":"13","author":"Gado","year":"2022","unstructured":"Gado MBaschant UHofbauer LC & Henneicke H2022Bad to the bone: the effects of therapeutic glucocorticoids on osteoblasts and osteocytes. Frontiers in Endocrinology13835720. (https:\/\/doi.org\/10.3389\/fendo.2022.835720)"},{"key":"bib23","series-title":"Cell","first-page":"645","article-title":"Functional domains of the human glucocorticoid receptor","volume":"46","author":"Gigu\u00e8re","year":"1986","unstructured":"Gigu\u00e8re VHollenberg SMRosenfeld MG & Evans RM1986Functional domains of the human glucocorticoid receptor. Cell46645\u2013652. (https:\/\/doi.org\/10.1016\/0092-8674(8690339-9)"},{"key":"bib24","series-title":"Frontiers in Neuroendocrinology","first-page":"273","article-title":"The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system: a critical evaluation of findings","volume":"29","author":"Haller","year":"2008","unstructured":"Haller JMikics E & Makara GB2008The effects of non-genomic glucocorticoid mechanisms on bodily functions and the central neural system: a critical evaluation of findings. Frontiers in Neuroendocrinology29273\u2013291. (https:\/\/doi.org\/10.1016\/j.yfrne.2007.10.004)"},{"key":"bib25","series-title":"Journal of Endocrinology","first-page":"R13","article-title":"Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action","volume":"230","author":"Hammond","year":"2016","unstructured":"Hammond GL2016Plasma steroid-binding proteins: primary gatekeepers of steroid hormone action. Journal of Endocrinology230R13\u2013R25. (https:\/\/doi.org\/10.1530\/JOE-16-0070)"},{"key":"bib26","series-title":"Journal of Autoimmunity","first-page":"104","article-title":"11beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis","volume":"92","author":"Hardy","year":"2018","unstructured":"Hardy RSFenton CCroft APNaylor AJBegum RDesanti GBuckley CDLavery GCooper MS & Raza K201811beta-hydroxysteroid dehydrogenase type 1 regulates synovitis, joint destruction, and systemic bone loss in chronic polyarthritis. Journal of Autoimmunity92104\u2013113. (https:\/\/doi.org\/10.1016\/j.jaut.2018.05.010)"},{"key":"bib27","series-title":"Nature Reviews. Rheumatology","first-page":"133","article-title":"Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases","volume":"16","author":"Hardy","year":"2020","unstructured":"Hardy RSRaza K & Cooper MS2020Therapeutic glucocorticoids: mechanisms of actions in rheumatic diseases. Nature Reviews. Rheumatology16133\u2013144. (https:\/\/doi.org\/10.1038\/s41584-020-0371-y)"},{"key":"bib28","series-title":"Proceedings of the Staff Meetings Mayo Clinic","first-page":"181","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis","volume":"24","author":"Hench","year":"1949","unstructured":"Hench PS & Kendall EC1949The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis. Proceedings of the Staff Meetings Mayo Clinic24181\u2013197."},{"key":"bib29","series-title":"Comprehensive Physiology","first-page":"603","article-title":"Regulation of the hypothalamic-pituitary-adrenocortical stress response","volume":"6","author":"Herman","year":"2016","unstructured":"Herman JPMcKlveen JMGhosal SKopp BWulsin AMakinson RScheimann J & Myers B2016Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comprehensive Physiology6603\u2013621. (https:\/\/doi.org\/10.1002\/cphy.c150015)"},{"key":"bib30","series-title":"BMC Genomics","first-page":"205","article-title":"Expression profiling of dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development","volume":"8","author":"James","year":"2007","unstructured":"James CGUlici VTuckermann JUnderhill TM & Beier F2007Expression profiling of dexamethasone-treated primary chondrocytes identifies targets of glucocorticoid signalling in endochondral bone development. BMC Genomics8205. (https:\/\/doi.org\/10.1186\/1471-2164-8-205)"},{"key":"bib31","series-title":"Endocrinology","first-page":"5592","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","unstructured":"Jia DO\u2019Brien CAStewart SAManolagas SC & Weinstein RS2006Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology1475592\u20135599. (https:\/\/doi.org\/10.1210\/en.2006-0459)"},{"key":"bib32","series-title":"Osteoporosis International","first-page":"38","article-title":"Mortality after osteoporotic fractures","volume":"15","author":"Johnell","year":"2004","unstructured":"Johnell OKanis JAOd\u00e9n ASernbo IRedlund-Johnell IPetterson CDe Laet C & J\u00f6nsson B2004Mortality after osteoporotic fractures. Osteoporosis International1538\u201342. (https:\/\/doi.org\/10.1007\/s00198-003-1490-4)"},{"key":"bib33","series-title":"Bone","first-page":"61","article-title":"Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice","volume":"45","author":"Kalak","year":"2009","unstructured":"Kalak RZhou HStreet JDay REModzelewski JRKSpies CMLiu PYLi GDunstan CR & Seibel MJ2009Endogenous glucocorticoid signalling in osteoblasts is necessary to maintain normal bone structure in mice. Bone4561\u201367. (https:\/\/doi.org\/10.1016\/j.bone.2009.03.673)"},{"key":"bib34","series-title":"Journal of Biological Chemistry","first-page":"44546","article-title":"Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations","volume":"287","author":"Khan","year":"2012","unstructured":"Khan SHAwasthi SGuo CGoswami DLing JGriffin PRSimons SS & Kumar R2012Binding of the N-terminal region of coactivator TIF2 to the intrinsically disordered AF1 domain of the glucocorticoid receptor is accompanied by conformational reorganizations. Journal of Biological Chemistry28744546\u201344560. (https:\/\/doi.org\/10.1074\/jbc.M112.411330)"},{"key":"bib35","series-title":"Journal of Clinical Investigation","first-page":"2152","article-title":"Glucocorticoids suppress bone formation via the osteoclast","volume":"116","author":"Kim","year":"2006","unstructured":"Kim HJZhao HKitaura HBhattacharyya SBrewer JAMuglia LJRoss FP & Teitelbaum SL2006Glucocorticoids suppress bone formation via the osteoclast. Journal of Clinical Investigation1162152\u20132160. (https:\/\/doi.org\/10.1172\/JCI28084)"},{"key":"bib36","series-title":"PNAS","first-page":"16425","article-title":"TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain","volume":"101","author":"Kumar","year":"2004","unstructured":"Kumar RVolk DELi JLee JCGorenstein DG & Thompson EB2004TATA box binding protein induces structure in the recombinant glucocorticoid receptor AF1 domain. PNAS10116425\u201316430. (https:\/\/doi.org\/10.1073\/pnas.0407160101)"},{"key":"bib37","series-title":"PLoS One","first-page":"e63578","article-title":"Deletion of mesenchymal glucocorticoid receptor attenuates embryonic lung development and abdominal wall closure","volume":"8","author":"Li","year":"2013","unstructured":"Li AHardy RStoner STuckermann JSeibel M & Zhou H2013Deletion of mesenchymal glucocorticoid receptor attenuates embryonic lung development and abdominal wall closure. PLoS One8e63578. (https:\/\/doi.org\/10.1371\/journal.pone.0063578)"},{"key":"bib38","series-title":"PLoS One","first-page":"e71318","article-title":"Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma","volume":"8","author":"Liu","year":"2013","unstructured":"Liu YStrecker SWang LKronenberg MSWang WRowe DW & Maye P2013Osterix-cre labeled progenitor cells contribute to the formation and maintenance of the bone marrow stroma. PLoS One8e71318. (https:\/\/doi.org\/10.1371\/journal.pone.0071318)"},{"key":"bib39","series-title":"Clinical Interventions in Aging","first-page":"1465","article-title":"Glucocorticoid-induced delayed fracture healing and impaired bone biomechanical properties in mice","volume":"13","author":"Liu","year":"2018","unstructured":"Liu YZAkhter MPGao XWang XYWang XBZhao GWei XWu HJChen HWang D, et al.2018Glucocorticoid-induced delayed fracture healing and impaired bone biomechanical properties in mice. Clinical Interventions in Aging131465\u20131474. (https:\/\/doi.org\/10.2147\/CIA.S167431)"},{"key":"bib40","series-title":"Molecular Cell","first-page":"331","article-title":"Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes","volume":"18","author":"Lu","year":"2005","unstructured":"Lu NZ & Cidlowski JA2005Translational regulatory mechanisms generate N-terminal glucocorticoid receptor isoforms with unique transcriptional target genes. Molecular Cell18331\u2013342. (https:\/\/doi.org\/10.1016\/j.molcel.2005.03.025)"},{"key":"bib41","series-title":"Nature","first-page":"497","article-title":"Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA","volume":"352","author":"Luisi","year":"1991","unstructured":"Luisi BFXu WXOtwinowski ZFreedman LPYamamoto KR & Sigler PB1991Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature352497\u2013505. (https:\/\/doi.org\/10.1038\/352497a0)"},{"key":"bib42","series-title":"Osteoarthritis and Cartilage","first-page":"1189","article-title":"Deletion of the chondrocyte glucocorticoid receptor attenuates cartilage degradation through suppression of early synovial activation in murine posttraumatic osteoarthritis","volume":"31","author":"Macfarlane","year":"2023","unstructured":"Macfarlane ECavanagh LFong-Yee CTuckermann JChen DLittle CBSeibel MJ & Zhou H2023Deletion of the chondrocyte glucocorticoid receptor attenuates cartilage degradation through suppression of early synovial activation in murine posttraumatic osteoarthritis. Osteoarthritis and Cartilage311189\u20131201. (https:\/\/doi.org\/10.1016\/j.joca.2023.04.009)"},{"key":"bib43","series-title":"American Journal of Respiratory Cell and Molecular Biology","first-page":"599","article-title":"Reduced viability of mice with lung epithelial-specific knockout of glucocorticoid receptor","volume":"43","author":"Manwani","year":"2010","unstructured":"Manwani NGagnon SPost MJoza SMuglia LCornejo SKaplan F & Sweezey NB2010Reduced viability of mice with lung epithelial-specific knockout of glucocorticoid receptor. American Journal of Respiratory Cell and Molecular Biology43599\u2013606. (https:\/\/doi.org\/10.1165\/rcmb.2009-0263OC)"},{"key":"bib44","series-title":"Neuropsychopharmacology","first-page":"1455","article-title":"Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients","volume":"37","author":"Menke","year":"2012","unstructured":"Menke AArloth JP\u00fctz BWeber PKlengel TMehta DGonik MRex-Haffner MRubel JUhr M, et al.2012Dexamethasone stimulated gene expression in peripheral blood is a sensitive marker for glucocorticoid receptor resistance in depressed patients. Neuropsychopharmacology371455\u20131464. (https:\/\/doi.org\/10.1038\/npp.2011.331)"},{"key":"bib45","series-title":"Canadian Journal of Surgery","first-page":"425","article-title":"Effects of cortisone and an anabolic androgen on the fractured humerus in guinea pigs: clinical and histological study over a six-week period of fracture healing","volume":"9","author":"Murakami","year":"1966","unstructured":"Murakami H & Kowalewski K1966Effects of cortisone and an anabolic androgen on the fractured humerus in guinea pigs: clinical and histological study over a six-week period of fracture healing. Canadian Journal of Surgery9425\u2013434."},{"key":"bib46","series-title":"Steroids","first-page":"1","article-title":"The human glucocorticoid receptor: molecular basis of biologic function","volume":"75","author":"Nicolaides","year":"2010","unstructured":"Nicolaides NCGalata ZKino TChrousos GP & Charmandari E2010The human glucocorticoid receptor: molecular basis of biologic function. Steroids751\u201312. (https:\/\/doi.org\/10.1016\/j.steroids.2009.09.002)"},{"key":"bib47","series-title":"Journal of Biological Chemistry","first-page":"3177","article-title":"Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids","volume":"286","author":"Oakley","year":"2011","unstructured":"Oakley RH & Cidlowski JA2011Cellular processing of the glucocorticoid receptor gene and protein: new mechanisms for generating tissue-specific actions of glucocorticoids. Journal of Biological Chemistry2863177\u20133184. (https:\/\/doi.org\/10.1074\/jbc.R110.179325)"},{"key":"bib48","series-title":"Journal of Biological Chemistry","first-page":"9550","article-title":"The human glucocorticoid receptor isoform: expression, biochemical properties, and putative function","volume":"271","author":"Oakley","year":"1996","unstructured":"Oakley RHSar M & Cidlowski JA1996The human glucocorticoid receptor isoform: expression, biochemical properties, and putative function. Journal of Biological Chemistry2719550\u20139559. (https:\/\/doi.org\/10.1074\/jbc.271.16.9550)"},{"key":"bib49","series-title":"Endocrinology","first-page":"1835","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O\u2019Brien","year":"2004","unstructured":"O\u2019Brien CAJia DPlotkin LIBellido TPowers CCStewart SAManolagas SC & Weinstein RS2004Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology1451835\u20131841. (https:\/\/doi.org\/10.1210\/en.2003-0990)"},{"key":"bib50","series-title":"Arthritis Research and Therapy","first-page":"271","article-title":"Widespread regulation of gene expression by glucocorticoids in chondrocytes from patients with osteoarthritis as determined by RNA-Seq","volume":"22","author":"Pemmari","year":"2020","unstructured":"Pemmari ALepp\u00e4nen TH\u00e4m\u00e4l\u00e4inen MMoilanen TVuolteenaho K & Moilanen E2020Widespread regulation of gene expression by glucocorticoids in chondrocytes from patients with osteoarthritis as determined by RNA-Seq. Arthritis Research and Therapy22271. (https:\/\/doi.org\/10.1186\/s13075-020-02289-7)"},{"key":"bib51","series-title":"Journal of Endocrinology","first-page":"27","article-title":"The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat","volume":"243","author":"Pierce","year":"2019","unstructured":"Pierce JLDing KHXu JSharma AKYu KDel Mazo Arbona NRodr\u00edguez-Santos ZBernard PJBollag WBJohnson MH, et al.2019The glucocorticoid receptor in osteoprogenitors regulates bone mass and marrow fat. Journal of Endocrinology24327\u201342. (https:\/\/doi.org\/10.1530\/JOE-19-0230)"},{"key":"bib52","series-title":"Journal of Bone and Mineral Research","first-page":"285","article-title":"The glucocorticoid receptor in osterix-expressing cells regulates bone mass, bone marrow adipose tissue, and systemic metabolism in female mice during aging","volume":"37","author":"Pierce","year":"2022","unstructured":"Pierce JLSharma AKRoberts RLYu KIrsik DLChoudhary VDorn JSBensreti HBenson RDKaiser H, et al.2022The glucocorticoid receptor in osterix-expressing cells regulates bone mass, bone marrow adipose tissue, and systemic metabolism in female mice during aging. Journal of Bone and Mineral Research37285\u2013302. (https:\/\/doi.org\/10.1002\/jbmr.4468)"},{"key":"bib53","series-title":"Neuroimmunomodulation","first-page":"46","article-title":"Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis","volume":"22","author":"Pincus","year":"2014","unstructured":"Pincus T & Cutolo M2014Clinical trials documenting the efficacy of low-dose glucocorticoids in rheumatoid arthritis. Neuroimmunomodulation2246\u201350. (https:\/\/doi.org\/10.1159\/000362734)"},{"key":"bib54","series-title":"Endocrine Reviews","first-page":"975","article-title":"Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?","volume":"44","author":"Pofi","year":"2023","unstructured":"Pofi RCaratti GRay DW & Tomlinson JW2023Treating the side effects of exogenous glucocorticoids; can we separate the good from the bad?Endocrine Reviews44975\u20131011. (https:\/\/doi.org\/10.1210\/endrev\/bnad016)"},{"key":"bib55","series-title":"FASEB Journal","first-page":"2235","article-title":"Induced global deletion of glucocorticoid receptor impairs fracture healing","volume":"32","author":"Rapp","year":"2018","unstructured":"Rapp AEHachemi YKemmler JKoenen MTuckermann J & Ignatius A2018Induced global deletion of glucocorticoid receptor impairs fracture healing. FASEB Journal322235\u20132245. (https:\/\/doi.org\/10.1096\/fj.201700459RR)"},{"key":"bib56","series-title":"Cell Metabolism","first-page":"517","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","unstructured":"Rauch ASeitz SBaschant USchilling AFIlling AStride BKirilov MMandic VTakacz ASchmidt-Ullrich R, et al.2010Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor. Cell Metabolism11517\u2013531. (https:\/\/doi.org\/10.1016\/j.cmet.2010.05.005)"},{"key":"bib57","series-title":"Bone and Joint Research","first-page":"170","article-title":"Glucocorticoids inhibit shaft fracture healing but not metaphyseal bone regeneration under stable mechanical conditions","volume":"4","author":"Sandberg","year":"2015","unstructured":"Sandberg OH & Aspenberg P2015Glucocorticoids inhibit shaft fracture healing but not metaphyseal bone regeneration under stable mechanical conditions. Bone and Joint Research4170\u2013175. (https:\/\/doi.org\/10.1302\/2046-3758.410.2000414)"},{"key":"bib58","series-title":"PNAS","first-page":"6174","article-title":"Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response","volume":"81","author":"Sapolsky","year":"1984","unstructured":"Sapolsky RMKrey LC & McEwan BS1984Glucocorticoid-sensitive hippocampal neurons are involved in terminating the adrenocortical stress response. PNAS816174\u20136177. (https:\/\/doi.org\/10.1073\/pnas.81.19.6174)"},{"key":"bib59","series-title":"Psychopathology of Human Adaptation","article-title":"Stress without distress","author":"Selye","year":"1976","unstructured":"Selye H1976Stress without distress. In Psychopathology of Human Adaptation. Serban G Ed. Boston, MA, USA: Springer."},{"key":"bib60","series-title":"Endocrinology","first-page":"922","article-title":"Transgenic expression of 11\u03b2-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone","volume":"145","author":"Sher","year":"2004","unstructured":"Sher LBWoitge HWAdams DJGronowicz GAKrozowski ZHarrison JR & Kream BE2004Transgenic expression of 11\u03b2-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone. Endocrinology145922\u2013929. (https:\/\/doi.org\/10.1210\/en.2003-0655)"},{"key":"bib61","series-title":"Calcified Tissue International","first-page":"118","article-title":"Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling","volume":"79","author":"Sher","year":"2006","unstructured":"Sher LBHarrison JRAdams DJ & Kream BE2006Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling. Calcified Tissue International79118\u2013125. (https:\/\/doi.org\/10.1007\/s00223-005-0297-z)"},{"key":"bib62","series-title":"British Journal of Surgery","first-page":"172","article-title":"The influence of cortisone on the repair of experimental fractures in the rabbit","volume":"39","author":"Sissons","year":"1951","unstructured":"Sissons HA & Hadfield GJ1951The influence of cortisone on the repair of experimental fractures in the rabbit. British Journal of Surgery39172\u2013178. (https:\/\/doi.org\/10.1002\/bjs.18003915411)"},{"key":"bib63","series-title":"Nature Reviews Disease Primers","first-page":"18001","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","unstructured":"Smolen JSAletaha DBarton ABurmester GREmery PFirestein GSKavanaugh AMcInnes IBSolomon DHStrand V, et al.2018Rheumatoid arthritis. Nature Reviews Disease Primers418001. (https:\/\/doi.org\/10.1038\/nrdp.2018.1)"},{"key":"bib64","series-title":"Pharmacology and Therapeutics","first-page":"28","article-title":"Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds","volume":"152","author":"Sundahl","year":"2015","unstructured":"Sundahl NBridelance JLibert CDe Bosscher K & Beck IM2015Selective glucocorticoid receptor modulation: new directions with non-steroidal scaffolds. Pharmacology and Therapeutics15228\u201341. (https:\/\/doi.org\/10.1016\/j.pharmthera.2015.05.001)"},{"key":"bib65","series-title":"Bone","first-page":"12","article-title":"Disruption of glucocorticoid signaling in chondrocytes delays metaphyseal fracture healing but does not affect normal cartilage and bone development","volume":"69","author":"Tu","year":"2014","unstructured":"Tu JHenneicke HZhang YStoner SCheng TLSchindeler AChen DTuckermann JCooper MSSeibel MJ, et al.2014Disruption of glucocorticoid signaling in chondrocytes delays metaphyseal fracture healing but does not affect normal cartilage and bone development. Bone6912\u201322. (https:\/\/doi.org\/10.1016\/j.bone.2014.08.016)"},{"key":"bib66","series-title":"American Journal of Pathology","first-page":"1293","article-title":"Transgenic disruption of glucocorticoid signaling in osteoblasts attenuates joint inflammation in collagen antibody-induced arthritis","volume":"186","author":"Tu","year":"2016","unstructured":"Tu JZhang YKim SWiebe ESpies CMButtgereit FCooper MSSeibel MJ & Zhou H2016Transgenic disruption of glucocorticoid signaling in osteoblasts attenuates joint inflammation in collagen antibody-induced arthritis. American Journal of Pathology1861293\u20131301. (https:\/\/doi.org\/10.1016\/j.ajpath.2015.12.025)"},{"key":"bib67","series-title":"FASEB Journal","first-page":"478","article-title":"Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damage","volume":"32","author":"Tu","year":"2018","unstructured":"Tu JStoner SFromm PDWang TChen DTuckermann JCooper MSSeibel MJ & Zhou H2018Endogenous glucocorticoid signaling in chondrocytes attenuates joint inflammation and damage. FASEB Journal32478\u2013487. (https:\/\/doi.org\/10.1096\/fj.201700659R)"},{"key":"bib68","series-title":"Osteoarthritis and Cartilage","first-page":"1518","article-title":"Disruption of glucocorticoid signalling in osteoblasts attenuates age-related surgically induced osteoarthritis","volume":"27","author":"Tu","year":"2019","unstructured":"Tu JZhang PJi ZHenneicke HLi JKim SSwarbrick MMWu YLittle CBSeibel MJ, et al.2019Disruption of glucocorticoid signalling in osteoblasts attenuates age-related surgically induced osteoarthritis. Osteoarthritis and Cartilage271518\u20131525. (https:\/\/doi.org\/10.1016\/j.joca.2019.04.019)"},{"key":"bib69","series-title":"Journal of Bone and Mineral Research","first-page":"993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"Van Staa","year":"2000","unstructured":"Van Staa TPLeufkens HGMAbenhaim LZhang B & Cooper C2000Use of oral corticosteroids and risk of fractures. Journal of Bone and Mineral Research15993\u20131000. (https:\/\/doi.org\/10.1359\/jbmr.2000.15.6.993)"},{"key":"bib70","series-title":"Osteoporosis International","first-page":"777","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"Van Staa","year":"2002","unstructured":"Van Staa TPLeufkens HG & Cooper C2002The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis. Osteoporosis International13777\u2013787. (https:\/\/doi.org\/10.1007\/s001980200108)"},{"key":"bib71","series-title":"ACR Open Rheumatology","first-page":"437","article-title":"Lowering expectations: glucocorticoid tapering among veterans with rheumatoid arthritis achieving low disease activity on stable biologic therapy","volume":"5","author":"Wallace","year":"2023","unstructured":"Wallace BIEngland BRBaker JFRojas JSauer BCRoul PKunkel GABraaten TJPetro AMikuls TR, et al.2023Lowering expectations: glucocorticoid tapering among veterans with rheumatoid arthritis achieving low disease activity on stable biologic therapy. ACR Open Rheumatology5437\u2013442. (https:\/\/doi.org\/10.1002\/acr2.11584)"},{"issue":"Supplement 68","key":"bib72","series-title":"Clinical and Experimental Rheumatology","first-page":"S68","article-title":"A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose-Prednisolone Trial","volume":"29","author":"Wassenberg","year":"2011","unstructured":"Wassenberg SRau RZeidler H & Low-Dose Prednisolone Trail Group2011A dose of only 5 mg prednisolone daily retards radiographic progression in early rheumatoid arthritis - the Low-Dose-Prednisolone Trial. Clinical and Experimental Rheumatology29 (Supplement 68) S68\u2013S72."},{"key":"bib73","series-title":"Acta Orthopaedica Scandinavica","first-page":"316","article-title":"Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model","volume":"71","author":"Waters","year":"2000","unstructured":"Waters RVGamradt SCAsnis PVickery BHAvnur ZHill E & Bostrom M2000Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model. Acta Orthopaedica Scandinavica71316\u2013321. (https:\/\/doi.org\/10.1080\/000164700317411951)"},{"key":"bib74","series-title":"Steroids","first-page":"282","article-title":"Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing","volume":"75","author":"Weber","year":"2010","unstructured":"Weber AJLi GKalak RStreet JButtgereit FDunstan CRSeibel MJ & Zhou H2010Osteoblast-targeted disruption of glucocorticoid signalling does not delay intramembranous bone healing. Steroids75282\u2013286. (https:\/\/doi.org\/10.1016\/j.steroids.2010.01.005)"},{"key":"bib75","series-title":"Bone","first-page":"573","article-title":"Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation","volume":"47","author":"Yang","year":"2010","unstructured":"Yang MTrettel LBAdams DJHarrison JRCanalis E & Kream BE2010Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation. Bone47573\u2013582. (https:\/\/doi.org\/10.1016\/j.bone.2010.06.002)"},{"key":"bib76","series-title":"Journal of Endocrinology","first-page":"291","article-title":"Macrophage 11\u03b2-HSD-1 deficiency promotes inflammatory angiogenesis","volume":"234","author":"Zhang","year":"2017","unstructured":"Zhang ZCoutinho AEMan TYKipari TMJHadoke PWFSalter DMSeckl JR & Chapman KE2017Macrophage 11\u03b2-HSD-1 deficiency promotes inflammatory angiogenesis. Journal of Endocrinology234291\u2013299. (https:\/\/doi.org\/10.1530\/JOE-17-0223)"},{"key":"bib77","series-title":"Journal of Biological Chemistry","first-page":"1936","article-title":"Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling","volume":"283","author":"Zhou","year":"2008","unstructured":"Zhou HMak WZheng YDunstan CR & Seibel MJ2008Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling. Journal of Biological Chemistry2831936\u20131945. (https:\/\/doi.org\/10.1074\/jbc.M702687200)"},{"key":"bib78","series-title":"Development","first-page":"427","article-title":"Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice","volume":"136","author":"Zhou","year":"2009","unstructured":"Zhou HMak WKalak RStreet JFong-Yee CZheng YDunstan CR & Seibel MJ2009Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice. Development136427\u2013436. (https:\/\/doi.org\/10.1242\/dev.027706)"},{"key":"bib79","series-title":"Bone Research","first-page":"107","article-title":"Endogenous glucocorticoids and bone","volume":"1","author":"Zhou","year":"2013","unstructured":"Zhou HCooper MS & Seibel MJ2013Endogenous glucocorticoids and bone. Bone Research1107\u2013119. (https:\/\/doi.org\/10.4248\/BR201302001)"}],"container-title":["Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/joe.bioscientifica.com\/view\/journals\/joe\/261\/2\/JOE-23-0399.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/261\/2\/JOE-23-0399.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/joe.bioscientifica.com\/downloadpdf\/journals\/joe\/261\/2\/JOE-23-0399.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T13:58:06Z","timestamp":1784555886000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.bioscientifica.com\/joe\/article\/5659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,7]]},"references-count":79,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/joe-23-0399","relation":{},"ISSN":["0022-0795","1479-6805"],"issn-type":[{"value":"0022-0795","type":"print"},{"value":"1479-6805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,7]]}}}